JP6920069B2 - How to increase the milk yield and milk fat content of ruminant livestock - Google Patents
How to increase the milk yield and milk fat content of ruminant livestock Download PDFInfo
- Publication number
- JP6920069B2 JP6920069B2 JP2017024219A JP2017024219A JP6920069B2 JP 6920069 B2 JP6920069 B2 JP 6920069B2 JP 2017024219 A JP2017024219 A JP 2017024219A JP 2017024219 A JP2017024219 A JP 2017024219A JP 6920069 B2 JP6920069 B2 JP 6920069B2
- Authority
- JP
- Japan
- Prior art keywords
- milk
- acetate
- vitamin
- fat content
- ruminant livestock
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 244000144972 livestock Species 0.000 title claims description 46
- 241000282849 Ruminantia Species 0.000 title claims description 36
- 235000013336 milk Nutrition 0.000 title description 70
- 239000008267 milk Substances 0.000 title description 70
- 210000004080 milk Anatomy 0.000 title description 70
- 235000021243 milk fat Nutrition 0.000 title description 36
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 claims description 109
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 77
- 235000012711 vitamin K3 Nutrition 0.000 claims description 53
- 239000011652 vitamin K3 Substances 0.000 claims description 53
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 24
- 229940041603 vitamin k 3 Drugs 0.000 claims description 24
- 241000283690 Bos taurus Species 0.000 claims description 22
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 19
- 239000004480 active ingredient Substances 0.000 claims description 17
- 230000004060 metabolic process Effects 0.000 claims description 16
- 229910052757 nitrogen Inorganic materials 0.000 claims description 15
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical group [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 10
- 239000001632 sodium acetate Substances 0.000 claims description 10
- 235000017281 sodium acetate Nutrition 0.000 claims description 10
- 230000003213 activating effect Effects 0.000 claims description 8
- 241000283707 Capra Species 0.000 claims description 7
- 241001494479 Pecora Species 0.000 claims description 7
- 239000001639 calcium acetate Substances 0.000 claims description 7
- 229960005147 calcium acetate Drugs 0.000 claims description 7
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 claims description 6
- 235000011092 calcium acetate Nutrition 0.000 claims description 6
- 159000000021 acetate salts Chemical class 0.000 claims description 3
- 235000011054 acetic acid Nutrition 0.000 description 22
- 230000001965 increasing effect Effects 0.000 description 22
- 235000013365 dairy product Nutrition 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 11
- 210000004767 rumen Anatomy 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 239000000047 product Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 6
- 239000003674 animal food additive Substances 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 229930003448 Vitamin K Natural products 0.000 description 4
- XKMRRTOUMJRJIA-UHFFFAOYSA-N ammonia nh3 Chemical compound N.N XKMRRTOUMJRJIA-UHFFFAOYSA-N 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 235000019168 vitamin K Nutrition 0.000 description 4
- 239000011712 vitamin K Substances 0.000 description 4
- 150000003721 vitamin K derivatives Chemical class 0.000 description 4
- 229940046010 vitamin k Drugs 0.000 description 4
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- -1 ctivating Species 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 102000014171 Milk Proteins Human genes 0.000 description 2
- 108010011756 Milk Proteins Proteins 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 241000209149 Zea Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000001465 calcium Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 235000012343 cottonseed oil Nutrition 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 238000003872 feeding technique Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 235000021239 milk protein Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000004460 silage Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000273 veterinary drug Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- DRCWOKJLSQUJPZ-DZGCQCFKSA-N (4ar,9as)-n-ethyl-1,4,9,9a-tetrahydrofluoren-4a-amine Chemical compound C1C2=CC=CC=C2[C@]2(NCC)[C@H]1CC=CC2 DRCWOKJLSQUJPZ-DZGCQCFKSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 241000282832 Camelidae Species 0.000 description 1
- 102000003846 Carbonic anhydrases Human genes 0.000 description 1
- 108090000209 Carbonic anhydrases Proteins 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 101001008429 Homo sapiens Nucleobindin-2 Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 102100027441 Nucleobindin-2 Human genes 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000003977 dairy farming Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000008642 heat stress Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 150000002829 nitrogen Chemical class 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 229960004109 potassium acetate Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229960004249 sodium acetate Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003716 vitamin K3 derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Landscapes
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
本発明は、反芻家畜の乳量及び乳脂肪含量増加方法等に関する。詳細には、経口投与又は給与成分により、簡便且つ効果的に、反芻家畜の窒素代謝を活性化させる方法、乳量と当該乳中の乳脂肪含量を同時に増加させる方法等に関する。 The present invention relates to a method for increasing the milk yield and milk fat content of ruminant livestock. More specifically, the present invention relates to a method for activating nitrogen metabolism in ruminant livestock by oral administration or feeding components, a method for simultaneously increasing milk yield and milk fat content in the milk, and the like.
牛、羊、山羊のように乳、肉などが商品となる反芻家畜においては、飼育している個体の体調不良や病気などによる乳量・乳質の低下、体重減少等は、酪農農家や畜産農家にとって深刻且つ直接的な経営問題となる。 In ruminant livestock such as cows, sheep, and goats, where milk and meat are commercial products, dairy farmers and livestock farmers are responsible for the deterioration of milk yield and quality, weight loss, etc. due to poor physical condition or illness of the breeding individuals. It becomes a serious and direct management problem for the farmers.
特に、乳又は乳加工品が商品となる反芻家畜(乳牛など)において、その乳量や乳質(乳脂肪含量、乳糖含量等)の低下は大きな問題となる。例えば、乳牛においては、夏季における暑熱ストレス(ヒートストレス)が乳脂肪を低下させ乳生産に多大な影響を及ぼしているため、低乳脂肪を防止する飼養技術の開発が当業界において望まれている。そこで、マルトース、スクロース、澱粉、ルーメンバイパスアミノ酸、トレハロースなどを用いた乳量増加技術(特許文献1〜4)や、脂肪酸カルシウムと酢酸ナトリウムの混合物や綿実油の給与による乳脂肪含量増加技術(非特許文献1)が提案され、また、乳量と乳脂肪含量の両方を高める技術の提案もいくつかなされている。 In particular, in ruminant livestock (dairy cows, etc.) for which milk or processed dairy products are commercial products, a decrease in milk yield and milk quality (milk fat content, lactose content, etc.) becomes a big problem. For example, in dairy cows, heat stress in summer reduces milk fat and has a great influence on milk production, so development of a feeding technique for preventing low milk fat is desired in the industry. .. Therefore, a technique for increasing milk yield using maltose, sucrose, starch, rumen bypass amino acid, trehalose, etc. (Patent Documents 1 to 4), and a technique for increasing milk fat content by feeding a mixture of fatty acid calcium and sodium acetate or cottonseed oil (non-patent). Document 1) has been proposed, and some techniques for increasing both milk yield and milk fat content have been proposed.
しかし、上記非特許文献1では乳量を高める効果は得られなかったと報告されており、さらに、綿実粕、脂肪酸カルシウムなどの飼料への添加は、ルーメン内発酵に悪影響を及ぼす可能性があることからその利用に当たっては飼養技術上難しいことが知られている。また、上記特許文献1〜3の技術も、利用方法が難しいという問題がある。そして、酪農の生産現場においては、乳量を増加させる方策をとると乳脂肪等の乳成分の割合・濃度が低下してしまう(薄まってしまう)のが通常であり、これまで提案された乳量と乳脂肪含量の両方を高める技術の実際の効果は極めて乏しく、乳牛等の乳量と乳脂肪含量を同時に高める飼養技術を開発することは非常に難しくなっている。 However, it is reported in Non-Patent Document 1 that the effect of increasing milk yield was not obtained, and further, addition of cottonseed meal, fatty acid calcium, etc. to feed may adversely affect fermentation in the rumen. Therefore, it is known that it is difficult to use it in terms of breeding technology. Further, the techniques of Patent Documents 1 to 3 also have a problem that they are difficult to use. At dairy production sites, if measures are taken to increase the amount of milk, the proportion and concentration of milk components such as milk fat usually decrease (dilute), and the milk proposed so far has been proposed. The actual effect of the technique for increasing both the amount and the milk fat content is extremely poor, and it is very difficult to develop a feeding technique for simultaneously increasing the milk yield and the milk fat content of dairy cows and the like.
このような背景技術において、当業界では、反芻家畜の乳量と乳脂肪含量を同時に高めることができるような新規な飼養技術、飼料成分等の開発、さらには、反芻家畜の乳生産と関連性があると言われている窒素代謝の活性化もできるような飼養技術、飼料成分等の開発が強く望まれていた。 In such background technology, in the industry, the development of new feeding technology, feed components, etc. that can simultaneously increase the milk yield and milk fat content of ruminant livestock, and further relevance to the milk production of ruminant livestock. There has been a strong desire to develop breeding techniques, feed components, etc. that can also activate nitrogen metabolism, which is said to be present.
一方、ビタミンK3(メナジオン)は合成品であり、ヒトでの利用は禁止されているが、家畜用としての利用は許可され、哺乳子ウシ用の飼料添加物として代用乳への添加などがされている。しかし、ビタミンK類は反芻家畜の第一胃内細菌によって合成されることが知られており、第一胃が発達した親ウシ、特に泌乳牛に対し、ビタミンK類は飼料添加物として利用されていない。 On the other hand, vitamin K3 (menadione) is a synthetic product and its use in humans is prohibited, but its use for livestock is permitted, and it is added to milk replacer as a feed additive for calves. ing. However, it is known that vitamin Ks are synthesized by rumen bacteria in the rumen, and vitamin Ks are used as feed additives for parent cows with developed rumen, especially lactating cows. Not.
このことから、ビタミンK類を泌乳牛等に経口投与又は給与することによる生理作用はほとんど知られておらず、ビタミンK3を反芻家畜へ経口投与又は給与することによる乳量、乳脂肪含量等への影響についての記載や示唆がある文献等は今のところ見出せない。 From this, little is known about the physiological effects of oral administration or feeding of vitamin K to lactating cows, etc., and the milk yield, milk fat content, etc. by oral administration or feeding of vitamin K3 to ruminant livestock, etc. No literature has been found so far that describes or suggests the effects of.
また、酢酸は、反芻家畜の第一胃内細菌により産生される主な揮発性脂肪酸(VFA)であり、反芻動物においてはグルコースに匹敵するくらい重要なエネルギー源である。この酢酸については、反芻家畜の唾液分泌を亢進させる(非特許文献2)と伴に、ルーメン粘膜の炭酸脱水酵素を活性化してルーメンからのVFAの吸収を促進する(非特許文献3)ことなどが報告されている。 In addition, acetic acid is a major volatile fatty acid (VFA) produced by rumen bacteria in ruminants, and is an important energy source comparable to glucose in ruminants. Regarding this acetic acid, along with enhancing saliva secretion of ruminant livestock (Non-Patent Document 2), it activates carbonic anhydrase of rumen mucosa to promote absorption of VFA from rumen (Non-Patent Document 3). Has been reported.
しかし、酢酸を反芻家畜へ経口投与又は給与することによる乳量、乳脂肪含量等への影響についての記載や示唆がある文献等は、ビタミンK3と同様に今のところ見出せない。 However, as with vitamin K3, no literature has been found so far that describes or suggests the effects of oral administration or feeding of acetic acid on ruminant livestock on milk yield, milk fat content, and the like.
本発明は、反芻家畜の窒素代謝を活性化し、また、その乳量及び当該乳中の乳脂肪含量を同時に増加させて、乳質及び乳生産量をともに改善できるような栄養生理学的技術(経口投与又は給与成分、方法等)の提供を目的としてなされたものである。 The present invention is a nutritional physiological technique (oral administration) capable of activating the nitrogen metabolism of ruminant livestock and simultaneously increasing the milk yield and the milk fat content in the milk to improve both milk quality and milk production. Or, it was made for the purpose of providing salary ingredients, methods, etc.).
上記目的を達成するため、本発明者らは鋭意研究の結果、反芻家畜に有効成分としてビタミンK3(メナジオン)、あるいは、酢酸及び/又は酢酸塩とビタミンK3(メナジオン)を一緒に経口投与又は給与することで、反芻家畜の窒素代謝を活性化し、及び/又は、その乳量と当該乳中の乳脂肪含量を同時に増加させ、乳質及び乳生産量を簡便且つ効果的に改善できることを見出し、本発明を完成するに至った。 In order to achieve the above object, as a result of diligent research, the present inventors have orally administered or fed vitamin K3 (menadione) or acetic acid and / or acetate and vitamin K3 (menadione) as an active ingredient to livestock. By doing so, it has been found that the nitrogen metabolism of reed livestock can be activated and / or the milk yield and the milk fat content in the milk can be increased at the same time, and the milk quality and milk production can be improved easily and effectively. The invention was completed.
すなわち、本発明の実施形態は次のとおりである。
(1)ビタミンK3(メナジオン)を有効成分とする反芻家畜の乳量及び乳脂肪含量増加用飼料組成物(反芻家畜用乳量及び乳脂肪含量増加剤)。
(2)酢酸及び/又は酢酸塩、及び、ビタミンK3(メナジオン)を有効成分とする反芻家畜の乳量及び乳脂肪含量増加用飼料組成物(特に、これら有効成分が同時に経口投与又は給与されるように含有してなる飼料組成物、反芻家畜用乳量及び乳脂肪含量増加剤)。
(3)酢酸及び/又は酢酸塩、及び、ビタミンK3(メナジオン)を有効成分とする反芻家畜の窒素代謝活性化用飼料組成物(特に、これら有効成分が同時に経口投与又は給与されるように含有してなる飼料組成物、反芻家畜用窒素代謝活性化剤)。
(4)酢酸塩が、酢酸ナトリウム及び/又は酢酸カルシウムである、(2)又は(3)に記載の飼料組成物。
(5)反芻家畜が、牛、羊、山羊から選ばれる少なくともひとつである、(1)〜(4)のいずれか1つに記載の飼料組成物。
(6)ビタミンK3(メナジオン)を反芻家畜に経口投与又は給与することを特徴とする、反芻家畜の乳量及び乳脂肪含量増加方法。
(7)酢酸及び/又は酢酸塩、及び、ビタミンK3(メナジオン)を反芻家畜に経口投与又は給与することを特徴とする、反芻家畜の乳量及び乳脂肪含量増加方法。
(8)酢酸及び/又は酢酸塩、及び、ビタミンK3(メナジオン)を反芻家畜に経口投与又は給与することを特徴とする、反芻家畜の窒素代謝活性化方法。
(9)酢酸及び/又は酢酸塩を1日当たり酢酸として(酢酸量換算で)30〜300g/頭、好ましくは60〜180g/頭経口投与又は給与することを特徴とする、(7)又は(8)に記載の方法。
(10)酢酸塩が、酢酸ナトリウム及び/又は酢酸カルシウムである、(7)〜(9)のいずれか1つに記載の方法。
(11)ビタミンK3(メナジオン)を1日当たり10〜200mg/頭、好ましくは10〜100mg/頭、更に好ましくは10〜50mg/頭経口投与又は給与することを特徴とする、(6)〜(10)のいずれか1つに記載の方法。
(12)反芻家畜が、牛、羊、山羊から選ばれる少なくともひとつである、(6)〜(11)のいずれか1つに記載の方法。
That is, the embodiment of the present invention is as follows.
(1) A feed composition for increasing the milk yield and milk fat content of ruminant livestock containing vitamin K3 (menadione) as an active ingredient (milk yield and milk fat content increasing agent for ruminant livestock).
(2) Feed composition for increasing milk yield and milk fat content of rebellious livestock containing acetic acid and / or acetate and vitamin K3 (menadion) as active ingredients (particularly, these active ingredients are orally administered or fed at the same time. Feed composition, milk yield and milk fat content increasing agent for rutted livestock).
(3) A feed composition for activating nitrogen metabolism in ruminant livestock containing acetic acid and / or acetate and vitamin K3 (menadione) as active ingredients (particularly, these active ingredients are contained so as to be orally administered or fed at the same time. Feed composition, ruminant livestock nitrogen metabolism activator).
(4) The feed composition according to (2) or (3), wherein the acetate salt is sodium acetate and / or calcium acetate.
(5) The feed composition according to any one of (1) to (4), wherein the ruminant livestock is at least one selected from cattle, sheep, and goats.
(6) A method for increasing the milk yield and milk fat content of ruminant livestock, which comprises orally administering or feeding vitamin K3 (menadione) to ruminant livestock.
(7) A method for increasing the milk yield and milk fat content of ruminant livestock, which comprises orally administering or feeding acetic acid and / or acetate and vitamin K3 (menadione) to ruminant livestock.
(8) A method for activating nitrogen metabolism in ruminant livestock, which comprises orally administering or feeding acetic acid and / or acetate and vitamin K3 (menadione) to ruminant livestock.
(9) Acetic acid and / or acetate as acetic acid per day (in terms of acetic acid amount) is orally administered or fed at 30 to 300 g / head, preferably 60 to 180 g / head, (7) or (8). ).
(10) The method according to any one of (7) to (9), wherein the acetate salt is sodium acetate and / or calcium acetate.
(11) Vitamin K3 (menadione) is orally administered or fed at 10 to 200 mg / head, preferably 10 to 100 mg / head, more preferably 10 to 50 mg / head per day, (6) to (10). ). The method according to any one of.
(12) The method according to any one of (6) to (11), wherein the ruminant livestock is at least one selected from cattle, sheep and goats.
本発明によれば、反芻家畜の窒素代謝を活性化し、及び/又は、その乳量と当該乳中の乳脂肪含量を同時に増加させ、乳質及び乳生産量を簡便且つ効果的に改善することができる。そして、本発明により、安定した反芻家畜の乳生産性あるいは乳生産性の向上、ならびに、酪農経営の安定化を図ることができる。 According to the present invention, it is possible to activate the nitrogen metabolism of ruminant livestock and / or simultaneously increase the milk yield thereof and the milk fat content in the milk to improve milk quality and milk production easily and effectively. can. Further, according to the present invention, it is possible to improve the milk productivity or milk productivity of stable ruminant livestock, and to stabilize the dairy farming business.
以下、本発明を詳細に説明する。 Hereinafter, the present invention will be described in detail.
本発明においては、反芻家畜の乳量及び乳脂肪含量増加、窒素代謝活性化の有効成分として、酢酸及び/又は酢酸塩、ビタミンK3(メナジオン)を使用する。 In the present invention, acetic acid and / or acetate and vitamin K3 (menadione) are used as active ingredients for increasing the milk yield and milk fat content of ruminant livestock and activating nitrogen metabolism.
酢酸、酢酸塩については、市販されている純品乾燥物などを使用することができ、酢酸塩としては、酢酸ナトリウム、酢酸カルシウム、酢酸カリウム、酢酸アンモニウムなどが例示される。本発明では、これらのうち、特に、酢酸、酢酸ナトリウム、酢酸カルシウムから選ばれる1以上を用いるのが非常に好適である。 As for acetic acid and acetate, commercially available pure dried products and the like can be used, and examples of the acetate include sodium acetate, calcium acetate, potassium acetate and ammonium acetate. In the present invention, it is very preferable to use one or more of these selected from acetic acid, sodium acetate and calcium acetate.
また、合成ビタミンであるビタミンK3(メナジオン)については、純品乾燥物が使用できることはもちろんのこと、その粗精製物(ペースト化物、希釈物、乳化物、懸濁物など)も使用可能である。また、デンプンやデキストリン等の賦形剤を加えて顆粒化したり、タブレットにしたりして製剤化したものも使用可能である。さらには、ルーメンで分解されないように油脂等でコーティングしたものも使用可能である。 As for vitamin K3 (menadione), which is a synthetic vitamin, not only a pure dried product can be used, but also a crude product thereof (paste, diluted product, emulsion, suspension, etc.) can be used. .. In addition, those formulated by adding excipients such as starch and dextrin to granules or tablets can also be used. Further, those coated with oil or fat so as not to be decomposed by lumens can also be used.
そして、このビタミンK3(メナジオン)を有効成分とし、あるいは、酢酸及び/又は酢酸塩とビタミンK3(メナジオン)を有効成分として併用し、そのまま飼料添加物、飼料、飼料組成物、動物医薬、その他の剤として使用することができる。また、常用される飼料成分を添加、混合して、飼料添加物、飼料、飼料組成物を提供することも可能であり、さらには、これらを有効成分とする動物医薬製剤としても提供することができる。この場合は、動物医薬製剤の常法にしたがって製剤化すればよく、他の生理機能を有する有効成分を併用することもできる。飼料添加物等とする場合でも、他の栄養成分(タンパク質、脂質、ミネラル(カリウム、ナトリウム、マグネシウム等)、ビタミンK3以外のビタミン(ビタミンA、ビタミンE等))などを併用できる。 Then, this vitamin K3 (menadione) is used as an active ingredient, or acetic acid and / or acetate and vitamin K3 (menadione) are used in combination as an active ingredient, and feed additives, feeds, feed compositions, veterinary drugs, and others are used as they are. It can be used as an agent. It is also possible to add and mix commonly used feed ingredients to provide feed additives, feeds and feed compositions, and further, it is possible to provide them as veterinary pharmaceutical preparations containing these as active ingredients. can. In this case, it may be formulated according to the conventional method of veterinary pharmaceutical preparation, and an active ingredient having other physiological functions may be used in combination. Even when it is used as a feed additive, other nutritional components (proteins, lipids, minerals (potassium, sodium, magnesium, etc.), vitamins other than vitamin K3 (vitamin A, vitamin E, etc.)) and the like can be used in combination.
本有効成分は、種々の形態で経口投与される。その投与形態としては例えば錠剤、カプセル剤、顆粒剤、散剤、シロップ剤等による経口投与などをあげることができる。これらの各種製剤は、常法に従って主薬に賦形剤、結合剤、崩壊剤、滑沢剤、矯味矯臭剤、溶解補助剤、懸濁剤、コーティング剤などの動物医薬剤等の製剤技術分野において通常使用しうる既知の補助剤を用いて製剤化することができる。なお、ビタミンK3(メナジオン)をそのまま、あるいは、酢酸及び/又は酢酸塩とビタミンK3(メナジオン)をそのまま混合して製剤として用いることも可能である。 The active ingredient is orally administered in various forms. Examples of the administration form include oral administration with tablets, capsules, granules, powders, syrups and the like. These various preparations are used in the field of formulation technology such as excipients, binders, disintegrants, lubricants, flavoring agents, solubilizing agents, suspending agents, coating agents and other veterinary pharmaceutical agents according to the conventional method. It can be formulated with a known auxiliary agent that can be commonly used. It is also possible to use vitamin K3 (menadione) as it is, or a mixture of acetic acid and / or acetate and vitamin K3 (menadione) as it is as a preparation.
なお、このようにして製剤化したものは、動物医薬剤として使用できるだけでなく、飼料組成物として使用することも充分可能であって、それ自体を飼料として直接家畜に給与することもできるし、飼料添加剤として他の飼料原料に添加、混合して用いることも可能である。 The product formulated in this way can be used not only as a veterinary drug, but also as a feed composition, and can be directly fed to livestock as a feed itself. It can also be added to other feed raw materials as a feed additive and mixed and used.
本発明の対象となる動物は、その乳及び/又は乳加工品が食用等となる泌乳期(通常は分娩後から12ヶ月程度まで)の反芻家畜である。例えば、乳牛(特にホルスタイン種、ジャージー種など)、羊、山羊などがより好適な対象動物として例示される。けれども、水牛、ラクダ、ヤクなどを対象としても構わない。 The animal to be the subject of the present invention is a ruminant livestock during the lactation period (usually up to about 12 months after calving) when the milk and / or processed milk product is edible. For example, dairy cows (particularly Holstein, Jersey, etc.), sheep, goats, etc. are exemplified as more suitable target animals. However, buffalo, camels, yaks, etc. may be targeted.
酢酸及び/又は酢酸塩、ビタミンK3(メナジオン)の反芻家畜への経口投与又は給与量としては、例えば乳牛であれば、酢酸及び/又は酢酸塩は1日・頭の経口投与又は給与で飼料の乾物当たり0.5〜5.0mol(酢酸量で換算すると30〜300g)、好ましくは1.0〜3.0mol(酢酸量で換算すると60〜180g)添加することが好適であり、ビタミンK3は10〜200mg、好ましくは10〜100mg、更に好ましくは10〜50mg、例えば10〜25mg程度添加することが好適である。そして、この量の経口投与又は給与を1日当たり2回程度に分けて行うのが好ましい。有効成分の経口投与又は給与量が当該範囲より多い場合、安全性やその効果という点において特段の問題はないが、コスト面などから上記範囲内の方が好ましい。また、当該範囲より少ない場合には、本発明の効果が十分発揮されない恐れがあるため好ましくない。
なお、他の反芻家畜においても、その体重等を勘案して経口投与又は給与量を設定すれば良いが、乳牛も含め上記以外の経口投与又は給与量を完全に除外するものではない。
As for the oral administration or feeding amount of acetic acid and / or acetate and vitamin K3 (menadion) to repetitive livestock, for example, in the case of dairy cows, acetic acid and / or acetate is given daily by oral administration or feeding of the head. It is preferable to add 0.5 to 5.0 mol (30 to 300 g in terms of acetic acid amount), preferably 1.0 to 3.0 mol (60 to 180 g in terms of acetic acid amount) per dry matter, and vitamin K3 is added. It is preferable to add 10 to 200 mg, preferably 10 to 100 mg, more preferably 10 to 50 mg, for example, about 10 to 25 mg. Then, it is preferable that this amount of oral administration or feeding is divided into about twice a day. When the amount of oral administration or feeding of the active ingredient is larger than the above range, there is no particular problem in terms of safety and its effect, but it is preferable to be within the above range from the viewpoint of cost. Further, if it is less than the above range, the effect of the present invention may not be sufficiently exhibited, which is not preferable.
For other ruminant livestock, oral administration or salary may be set in consideration of their body weight, etc., but oral administration or salary other than the above, including dairy cows, is not completely excluded.
本発明は、ビタミンK3(メナジオン)、あるいは、酢酸及び/又は酢酸塩とビタミンK3(メナジオン)の併用の有効性(乳量と乳脂肪含量の同時増加や窒素代謝活性化)を実際の生産現場における反芻家畜生体を用いて直接確認し、特に、これまで非常に困難であるとされてきた乳牛等の乳量と乳脂肪含量を同時に高める作用の科学的立証がなされた極めて実用的なものであると言える。 The present invention shows the effectiveness of the combined use of vitamin K3 (menadione) or acetic acid and / or acetate and vitamin K3 (menadione) (simultaneous increase in milk yield and milk fat content and activation of nitrogen metabolism) at an actual production site. It is a very practical one that has been directly confirmed using the living body of the slaughtered livestock in Japan, and in particular, has been scientifically proven to have the effect of simultaneously increasing the milk yield and milk fat content of dairy cows, etc., which have been considered to be extremely difficult. It can be said that there is.
なお、本発明において「乳脂肪含量を高める」、「乳脂肪量の増加」とは、乳中の脂肪含量全体(総量)が増加することを意味し、乳脂肪中の特定の脂肪酸比率が高まること(総量は変わらないこと)とは意味が異なる。 In the present invention, "increasing the milk fat content" and "increasing the amount of milk fat" mean that the total fat content (total amount) in the milk increases, and the ratio of a specific fatty acid in the milk fat increases. The meaning is different from that (the total amount does not change).
以下、本発明の実施例について述べるが、本発明はこれらの実施例のみに限定されるものではなく、本発明の技術的思想内においてこれらの様々な変形が可能である。 Hereinafter, examples of the present invention will be described, but the present invention is not limited to these examples, and various modifications thereof are possible within the technical idea of the present invention.
ホルスタイン種泌乳牛7頭(平均乳量28kg、平均分娩後日数217.1日、平均産次数2)を供試し、試験を行った。飼養試験期間中は、コーンサイレージと乳牛配合飼料を主体とした慣行飼料を1日2回給餌し自由採食・自由飲水とした。朝夕の給餌ごとに、酢酸ナトリウム;125gと市販のビタミンK3;1g(1%換算=10mg)を処理区の餌に同時添加し、対照区は無添加とした。11日間の予備試験と3日間の試験の14日間を一期として、2期の反転試験を行った。 Seven Holstein lactating cows (average milk yield 28 kg, average postpartum days 217.1 days, average calving order 2) were tested and tested. During the feeding test period, conventional feed mainly composed of corn silage and dairy cow mixed feed was fed twice a day for free feeding and free drinking. Sodium acetate; 125 g and commercially available vitamin K3; 1 g (1% conversion = 10 mg) were simultaneously added to the diet of the treatment group for each morning and evening feed, and no control group was added. A two-term reversal test was performed with 14 days of the 11-day preliminary test and the 3-day test as one period.
まず、飼養試験において、対照区と処理区におけるルーメン発酵について比較した。この結果を下記表1に示した。給餌前0時間、給餌後5時間目において、ルーメン内総VFA濃度及びVFA組成を比較したところ、両区において有意差は見られなかった。しかし、アンモニア態窒素濃度は給餌後5時間目で処理区において有意に低い値を示した(P<0.05)。 First, in the feeding test, the rumen fermentation in the control group and the treatment group was compared. The results are shown in Table 1 below. When the total VFA concentration in the lumen and the VFA composition were compared 0 hours before feeding and 5 hours after feeding, no significant difference was observed between the two groups. However, the ammonia nitrogen concentration showed a significantly low value in the treated group 5 hours after feeding (P <0.05).
次に、血液代謝産物の濃度変化の結果を下記表2に示した。血液中遊離脂肪酸(NEFA)、グルコース及びトリグリセリドの濃度は両区において有意な差は見られなかったが、血中尿素態窒素濃度は処理区で有意に低い値を示した(P<0.05)。 Next, the results of changes in the concentration of blood metabolites are shown in Table 2 below. The blood free fatty acid (NEFA), glucose and triglyceride concentrations were not significantly different between the two groups, but the blood urea nitrogen concentration was significantly lower in the treated group (P <0.05). ).
さらに、乾物摂取量、乳量、乳成分の変化の結果について下記表3に示した。両区において乾物摂取量には差が見られなかったが、乳量は処理区において有意に高い値を示した(P<0.01)。乳成分においても、乳脂肪含量は処理区において有意に高い値を示した(P<0.05)。また、乳タンパク質含量は処理区において、有意に低い値を示した(P<0.01)。 Furthermore, the results of changes in dry matter intake, milk yield, and milk components are shown in Table 3 below. There was no difference in dry matter intake between the two plots, but milk yield was significantly higher in the treated plots (P <0.01). As for the milk component, the milk fat content was significantly higher in the treated group (P <0.05). In addition, the milk protein content was significantly lower in the treated group (P <0.01).
さらに、この試験における、ルーメン内アンモニア態窒素、血中尿素態窒素濃度(BUN)、乳中尿素態窒素濃度(MUN)の変化を図1に示した。酢酸ナトリウムとビタミンK3の飼料への添加によりルーメン内アンモニア態窒素とBUNは有意に低下し(P<0.05)、MUNも有意に低下し(P<0.01)、窒素代謝が活性化していると認められた。 Furthermore, changes in lumen ammonia nitrogen, blood urea nitrogen concentration (BUN), and milk urea nitrogen concentration (MUN) in this test are shown in FIG. Addition of sodium acetate and vitamin K3 to the diet significantly reduced lumen ammonia nitrogen and BUN (P <0.05), significantly reduced MUN (P <0.01), and activated nitrogen metabolism. Was admitted.
以上の結果から、有効成分として酢酸ナトリウムとビタミンK3の併用給与は、泌乳牛の窒素代謝を活性化し、さらに、乳量、乳脂肪含量の両方を同時に高めることが示された。また、継続給与の安全性及び持続効果についても明らかとなった。 From the above results, it was shown that the combined feeding of sodium acetate and vitamin K3 as active ingredients activates nitrogen metabolism in lactating cows and further increases both milk yield and milk fat content at the same time. In addition, the safety and sustainability of continuous salary were also clarified.
ホルスタイン種泌乳牛6頭(平均乳量19kg、平均搾乳日数241日、平均産次数1.8)を供試し、試験を行った。飼養試験期間中は、コーンサイレージと乳牛配合飼料を主体とした慣行飼料を1日2回給餌し自由採食・自由飲水とした。朝夕の給餌ごとに市販のビタミンK3;2.5g(1%換算=25mg、50mg/日)をビタミンK区の餌に添加し、対照区は無添加とした。11日間の予備試験と3日間の試験の14日間を一期として、反転試験を行った。 Six Holstein lactating cows (average milk yield 19 kg, average milking days 241 days, average production order 1.8) were tested and tested. During the feeding test period, conventional feed mainly composed of corn silage and dairy cow mixed feed was fed twice a day for free feeding and free drinking. Commercially available vitamin K3; 2.5 g (1% conversion = 25 mg, 50 mg / day) was added to the diet of vitamin K group for each morning and evening feeding, and no control group was added. A reversal test was performed with 14 days of the 11-day preliminary test and the 3-day test as one period.
試験後の対照区とビタミンK区における乾物摂取量(DMI)、ルーメンでのメタン(CH4)生成量、乳量、乳成分組成(乳脂肪、乳蛋白質、乳糖)、乳中尿素態窒素の測定結果について下記表4に示した。両区において乾物摂取量には差が見られなかったが、乳量及び乳脂肪含量の両方がビタミンK区において有意に高い値を示した。なお、表中の数値右側にあるアルファベットが各区で同じであれば有意差なし、異なれば有意差ありを表す。 Dry matter intake (DMI), methane (CH 4 ) production in rumen, milk yield, milk composition (milk fat, milk protein, lactose), urea nitrogen in milk in the control group and vitamin K group after the test The measurement results are shown in Table 4 below. There was no difference in dry matter intake between the two groups, but both milk yield and milk fat content were significantly higher in the vitamin K group. If the alphabet on the right side of the numerical value in the table is the same in each section, it means that there is no significant difference, and if it is different, it means that there is a significant difference.
以上の結果から、有効成分としてビタミンK3の単独給与も、泌乳牛の乳量、乳脂肪含量の両方を同時に高めることが示された。 From the above results, it was shown that the single feeding of vitamin K3 as an active ingredient also increases both the milk yield and the milk fat content of lactating cows at the same time.
なお、本発明を要約すれば次のとおりである。 The present invention can be summarized as follows.
すなわち、本発明は、牛、羊、山羊などの反芻家畜の窒素代謝を活性化し、また、その乳量及び当該乳中の乳脂肪含量を同時に増加させて、乳質及び乳生産量をともに改善できるような栄養生理学的技術(経口投与又は給与成分、方法等)を提供することを目的とする。 That is, the present invention can improve both milk quality and milk production by activating the nitrogen metabolism of ruminant livestock such as cows, sheep and goats, and simultaneously increasing the milk yield and the milk fat content in the milk. It is an object of the present invention to provide such nutritional and physiological techniques (oral administration or feeding ingredients, methods, etc.).
そして、有効成分としてビタミンK3(メナジオン)、あるいは、酢酸及び/又は酢酸塩とビタミンK3(メナジオン)を反芻家畜に経口投与又は給与することで、反芻家畜の窒素代謝を活性化し、及び/又は、その乳量と当該乳中の乳脂肪含量を同時に増加させ、乳質及び乳生産量を簡便且つ効果的に改善する。 Then, by orally administering or feeding vitamin K3 (menadion) or acetic acid and / or acetate and vitamin K3 (menadion) as an active ingredient to the rubbing livestock, the nitrogen metabolism of the rubbing livestock is activated and / or The milk yield and the milk fat content in the milk are increased at the same time to improve milk quality and milk production easily and effectively.
Claims (8)
The method according to any one of claims 4 to 7 , wherein the ruminant livestock is at least one selected from cattle, sheep, and goats.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016043845 | 2016-03-07 | ||
JP2016043845 | 2016-03-07 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021021307A Division JP7066888B2 (en) | 2016-03-07 | 2021-02-12 | Method of increasing milk yield and milk fat content of ruminant livestock |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017158539A JP2017158539A (en) | 2017-09-14 |
JP6920069B2 true JP6920069B2 (en) | 2021-08-18 |
Family
ID=59853606
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017024219A Active JP6920069B2 (en) | 2016-03-07 | 2017-02-13 | How to increase the milk yield and milk fat content of ruminant livestock |
JP2021021307A Active JP7066888B2 (en) | 2016-03-07 | 2021-02-12 | Method of increasing milk yield and milk fat content of ruminant livestock |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021021307A Active JP7066888B2 (en) | 2016-03-07 | 2021-02-12 | Method of increasing milk yield and milk fat content of ruminant livestock |
Country Status (1)
Country | Link |
---|---|
JP (2) | JP6920069B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7444707B2 (en) * | 2020-06-18 | 2024-03-06 | 明治飼糧株式会社 | Livestock colostrum quality improving agent and method |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2542655B2 (en) * | 1987-01-19 | 1996-10-09 | 日清製粉株式会社 | Mixed feed for animals |
JPH04281753A (en) * | 1991-03-07 | 1992-10-07 | Nakano Vinegar Co Ltd | Feeding of feed |
JP4281753B2 (en) | 2006-03-10 | 2009-06-17 | セイコーエプソン株式会社 | Method for manufacturing thin film semiconductor device |
-
2017
- 2017-02-13 JP JP2017024219A patent/JP6920069B2/en active Active
-
2021
- 2021-02-12 JP JP2021021307A patent/JP7066888B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2017158539A (en) | 2017-09-14 |
JP7066888B2 (en) | 2022-05-13 |
JP2021072864A (en) | 2021-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230059330A1 (en) | Encapsulation of nutritional and/or compounds for controlled release and enhancing their bioavailability by limiting chemical or microbial exposure | |
ES2943679T3 (en) | Reproductive capacity enhancement agent for a ruminant | |
JPH06153811A (en) | Liquid feed cmpoition for juvenile livestock | |
TW200539821A (en) | Alkaloid-containing feed and feed additive | |
JP7026429B2 (en) | Feed composition for immunostimulatory of ruminant livestock | |
JP7066888B2 (en) | Method of increasing milk yield and milk fat content of ruminant livestock | |
US20140228329A1 (en) | Use of 25-hydroxy vitamin d3 to promote phosphorous utilisation in ruminants | |
RU2676318C1 (en) | Method of application of fodder additive for bull calves | |
CA2995626C (en) | Methods and formulations for reducing bovine emissions | |
JP5399395B2 (en) | Composition for increasing milk production of livestock containing wormwood | |
Mohammadi et al. | Effects of prepartum monensin feeding on energy metabolism and reproductive performance of postpartum high-producing Holstein dairy cows | |
JPS6368046A (en) | Preparation for animal | |
JP3433212B2 (en) | How to improve beef quality | |
JP7444707B2 (en) | Livestock colostrum quality improving agent and method | |
Bohnert et al. | Late gestation supplementation of beef cows: effects on cow and calf performance | |
Elmali et al. | Effects of supplementation with different amounts of malic acid to Tuj lambs diets on fattening performance, rumen parameters and digestibility | |
JPS62272945A (en) | Preparation for animal | |
WO2020243975A1 (en) | Use of nutraceutical composition in animal feed | |
RU2085074C1 (en) | Method for prophylaxis, normalization and therapy of metabolic disturbances and diseases of young cattle | |
NL2007581C2 (en) | Method for preventing osteochondrosis. | |
Garcia-Ascolani et al. | 1327 Effect of frequency of supplementation with Megalac-R on non-esterified fatty acids and blood urea nitrogen concentration in lactating beef cows | |
JPH02255047A (en) | Improvement in absorbed amount of amino acid of ruminant | |
JPS62143647A (en) | Meat quality improver | |
Hosseinkhani et al. | Effect of physical processing of diet on eating and ruminating behaviors of dairy cows in early lactation | |
HU203040B (en) | Process for producing weight-increasing composition containing 1-(3,5-dihydroxy-phenyl)-2-(terc-butyl-amino)-ethanol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200203 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20201209 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20201215 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210212 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210629 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210726 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6920069 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |